Drug profile · INN
aripiprazole lauroxil
ARISTADA INITIO KIT
aripiprazole lauroxil (ARISTADA INITIO KIT) is a serotonin 2a (5-ht2a) receptor antagonist. Route of administration: intramuscular. Current US regulatory status: approved.
Drug details — aripiprazole lauroxil
- US status
- approved
- Class
- —
- Route
- INTRAMUSCULAR
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
aripiprazole lauroxil (ARISTADA INITIO KIT) is a serotonin 2a (5-ht2a) receptor antagonist. Route of administration: intramuscular. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin 2a (5-HT2a) receptor antagonist
Primary target: D(2) dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is aripiprazole lauroxil?
aripiprazole lauroxil (ARISTADA INITIO KIT) is a serotonin 2a (5-ht2a) receptor antagonist. Route of administration: intramuscular. Current US regulatory status: approved.
What is the brand name for aripiprazole lauroxil?
ARISTADA INITIO KIT is a marketed brand name for aripiprazole lauroxil. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of aripiprazole lauroxil?
aripiprazole lauroxil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.